{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:02:09Z","timestamp":1770742929835,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Travere Therapeutics Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11136-025-03951-w","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:15:39Z","timestamp":1744384539000},"page":"1925-1937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The humanistic burden of focal segmental glomerulosclerosis on patients and care-partners in the United States"],"prefix":"10.1007","volume":"34","author":[{"given":"Justyna","family":"Szklarzewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Floege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisha","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Helm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Poyan-Mehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Hendry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget L.","family":"Balkaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam K.","family":"Jauregui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Nason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha C.","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-7898","authenticated-orcid":false,"given":"Mark","family":"Bensink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"3","key":"3951_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg, A. Z., & Kopp, J. B. (2017). Focal segmental glomerulosclerosis. Clinical Journal of the American Society of Nephrology, 12(3), 502\u2013517.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"3951_CR2","doi-asserted-by":"crossref","unstructured":"Bensink M, Thakker K, Lerma E, Velez J, Lieblich R, Bunke M, Wang K, Amari D, Thanataveerat A, Oliveri D, Rava A, Cork D. Poster# EE265: Focal segmental glomerulosclerosis (FSGS) in adults: A retrospective analysis of us prevalence and impacts of proteinuria and kidney function decline on healthcare resource utilization (HRU) and costs. Presented at: ISPOR 2022; Washington, DC, US.","DOI":"10.1016\/j.jval.2022.04.512"},{"issue":"9","key":"3951_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000508099","volume":"144","author":"A Shabaka","year":"2020","unstructured":"Shabaka, A., Tato Ribera, A., & Fern\u00e1ndez-Ju\u00e1rez, G. (2020). Focal segmental glomerulosclerosis: State-of-the-art and clinical perspective. Nephron, 144(9), 413\u2013427.","journal-title":"Nephron"},{"issue":"4","key":"3951_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1053\/j.ajkd.2016.03.416","volume":"68","author":"JJ Sim","year":"2016","unstructured":"Sim, J. J., Batech, M., Hever, A., Harrison, T. N., Avelar, T., Kanter, M. H., & Jacobsen, S. J. (2016). Distribution of biopsy-proven presumed primary glomerulonephropathies in 2000\u20132011 among a racially and ethnically diverse US population. American Journal of Kidney Diseases, 68(4), 533\u2013544.","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"3951_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/rai2.12068","volume":"3","author":"S Kitajima","year":"2023","unstructured":"Kitajima, S., Osima, M., Ogura, H., Nakagawa, S., Yamamura, Y., Miyake, T., Miyagawa, T., Toyama, T., Hara, A., Sakai, N., Shimizu, M., Wada, T., & Iwata, Y. (2023). Long-term prognosis of focal segmental glomerulosclerosis treated with therapeutic low-density lipoprotein-apheresis in patients with severe kidney dysfunction and proteinuria. Rheumatology & Autoimmunity, 3(1), 35\u201342.","journal-title":"Rheumatology & Autoimmunity"},{"issue":"8","key":"3951_CR6","doi-asserted-by":"publisher","first-page":"e2228701","DOI":"10.1001\/jamanetworkopen.2022.28701","volume":"5","author":"DS Gipson","year":"2022","unstructured":"Gipson, D. S., Troost, J. P., Spino, C., Attalla, S., Tarnoff, J., Massengill, S., Lafayette, R., Vega-Warner, V., Adler, S., Gipson, P., Elliott, M., Kaskel, F., Fermin, D., Moxey-Mims, M., Fine, R. N., Brown, E. J., Reidy, K., Tuttle, K., Gibson, K., \u2026 Trachtman, H. (2022). Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis. JAMA Network Open, 5(8), e2228701\u2013e2228701.","journal-title":"JAMA Network Open"},{"issue":"5","key":"3951_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","volume":"44","author":"C Kitiyakara","year":"2004","unstructured":"Kitiyakara, C., Eggers, P., & Kopp, J. B. (2004). Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. American Journal of Kidney Diseases, 44(5), 815\u2013825.","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"3951_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/0886022X.2017.1398667","volume":"39","author":"L Wu","year":"2017","unstructured":"Wu, L., Zhang, P., Yang, Y., Jiang, H., He, Y., Xu, C., Yan, H., Guo, Q., Luo, Q., & Chen, J. (2017). Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy. Renal Failure, 39(1), 736\u2013744.","journal-title":"Renal Failure"},{"issue":"1","key":"3951_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12882-020-02135-7","volume":"21","author":"ED Ferreira","year":"2020","unstructured":"Ferreira, E. D., Moreira, T. R., daSilva, R. G., daCosta, G. D., daSilva, L. S., Cavalier, S. B., Silva, B. O., Dias, H. H., Borges, L. D., Machado, J. C., & Cotta, R. M. (2020). Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: A 20-year cohort. BMC Nephrology., 21(1), 502.","journal-title":"BMC Nephrology."},{"issue":"10","key":"3951_CR10","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.ekir.2021.07.030","volume":"6","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh, K., Baker, C. L., Copley, J. B., Levy, D. I., Berasi, S., Tamimi, N., Alvir, J., & Udani, S. M. (2021). A retrospective study of clinical and economic burden of focal segmental glomerulosclerosis (FSGS) in the United States. Kidney International Reports, 6(10), 2679\u20132688.","journal-title":"Kidney International Reports"},{"issue":"2","key":"3951_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100760","volume":"6","author":"ME Bensink","year":"2024","unstructured":"Bensink, M. E., Goldschmidt, D., Zhou, Z. Y., Wang, K., Lieblich, R., & Bunke, C. M. (2024). Kidney failure attributed to focal segmental glomerulosclerosis: A USRDS retrospective cohort study of epidemiology, treatment modalities, and economic burden. Kidney Medicine, 6(2), 100760.","journal-title":"Kidney Medicine"},{"issue":"3","key":"3951_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ki.2014.86","volume":"86","author":"M Artom","year":"2014","unstructured":"Artom, M., Moss-Morris, R., Caskey, F., & Chilcot, J. (2014). Fatigue in advanced kidney disease. Kidney International, 86(3), 497\u2013505.","journal-title":"Kidney International"},{"issue":"6","key":"3951_CR13","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.ajkd.2019.08.026","volume":"75","author":"K Legrand","year":"2020","unstructured":"Legrand, K., Speyer, E., Stengel, B., Frimat, L., Ngueyon Sime, W., Massy, Z. A., Fouque, D., Laville, M., Combe, C., Jacquelinet, C., Durand, A. C., Edet, S., Gentile, S., Brian\u00e7on, S., & Ayav, C. (2020). Perceived health and quality of life in patients with CKD, including those with kidney failure: Findings from national surveys in France. American Journal of Kidney Diseases, 75(6), 868\u2013878.","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"3951_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1590\/S1807-59322011000600012","volume":"66","author":"MC Cruz","year":"2011","unstructured":"Cruz, M. C., Andrade, C., Urrutia, M., Draibe, S., & Nogueira-Martins, L. A. (2011). Quality of life in patients with chronic kidney disease. Clinics, 66(6), 991\u2013995.","journal-title":"Clinics"},{"issue":"1","key":"3951_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12877-020-01697-3","volume":"20","author":"R Artzi-Medvedik","year":"2020","unstructured":"Artzi-Medvedik, R., Kob, R., Fabbietti, P., Lattanzio, F., Corsonello, A., Melzer, Y., Roller-Wirnsberger, R., Wirnsberger, G., Mattace-Raso, F., Tap, L., Gil, P., Martinez, S. L., Formiga, F., Moreno-Gonz\u00e1lez, R., Kostka, T., Guligowska, A., \u00c4rnl\u00f6v, J., Carlsson, A. C., Freiberger, E., \u2026 on behalf of the SCOPE investigators. (2020). Impaired kidney function is associated with lower quality of life among community-dwelling older adults. BMC Geriatrics, 20(1), 340.","journal-title":"BMC Geriatrics"},{"issue":"2","key":"3951_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/archdischild-2018-314934","volume":"104","author":"A Francis","year":"2019","unstructured":"Francis, A., Didsbury, M. S., Zwieten, A. V., Chen, K., James, L. J., Kim, S., Howard, K., Williams, G., Treidel, O. B., McTaggart, S., Walker, A., Mackie, F., Kara, T., Nassar, N., Teixeira-Pinto, A., Tong, A., Johnson, D., Craig, J. C., & Wong, G. (2019). Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Archives of Disease in Childhood, 104(2), 134\u2013140.","journal-title":"Archives of Disease in Childhood"},{"key":"3951_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jped.2014.03.002","volume":"90","author":"CG Teixeira","year":"2014","unstructured":"Teixeira, C. G., Duarte, Md. C., Prado, C. M., Albuquerque, E. C. D., & Andrade, L. B. (2014). Impact of chronic kidney disease on quality of life, lung function, and functional capacity. Jornal de Pediatria, 90, 580\u2013586.","journal-title":"Jornal de Pediatria"},{"key":"3951_CR18","doi-asserted-by":"crossref","unstructured":"Szklarzewicz J, HONUS Advisory Board Members and HONUS Study Team. PO1479: Humanistic burden of rare kidney diseases; understanding the impact of FSGS and IgAN on patients and caregivers: The HONUS rationale and study design. Presented at: Kidney Week; November 4\u20137, 2021 San Diego, CA.","DOI":"10.1681\/ASN.20213210S1466b"},{"key":"3951_CR19","unstructured":"ClinicalTrials.gov. NCT05200871: Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy) (HONUS). Retrieved from February 22, 2024, https:\/\/classic.clinicaltrials.gov\/ct2\/show\/results\/NCT05200871?view=results"},{"key":"3951_CR20","unstructured":"Kosinski M, Ware J, Turner-Bowker D, Gandek B. User's manual for the Sf-12v2 Health Survey: With a supplement documenting the Sf-12\u00ae Health Survey. QualityMetric, Inc.; 2007."},{"issue":"5","key":"3951_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics, 4(5), 353\u2013365.","journal-title":"PharmacoEconomics"},{"key":"3951_CR22","unstructured":"National Health and Wellness Survey (NHWS). Cerner Enviza. Retrieved from December 14, 2023. https:\/\/www.cernerenviza.com\/real-world-data\/national-health-and-wellness-survey-nhws"},{"issue":"2","key":"3951_CR23","first-page":"81","volume":"19","author":"G Kalton","year":"2003","unstructured":"Kalton, G., & Flores-Cervantes, I. (2003). Weighting methods. Journal of Official Statics., 19(2), 81.","journal-title":"Journal of Official Statics."},{"key":"3951_CR24","unstructured":"Davern M, Strief J. IPUMS user note: Issues concerning the calculation of standard errors (i.e., variance estimation) using IPUMS data products. Retrieved from January 7, 2024, https:\/\/international.ipums.org\/international\/resources\/misc_docs\/user_note_variance.pdf"},{"issue":"3","key":"3951_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","volume":"4","author":"GM Sullivan","year":"2012","unstructured":"Sullivan, G. M., & Feinn, R. (2012). Using effect size-or why the p value is not enough. Journal of Graduate Medical Education, 4(3), 279\u2013282.","journal-title":"Journal of Graduate Medical Education"},{"issue":"24","key":"3951_CR26","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware Jr","year":"2000","unstructured":"Ware, J. E., Jr. (2000). SF-36 health survey update. Spin (Phila Pa 1976), 25(24), 3130\u20139.","journal-title":"Spin (Phila Pa 1976)"},{"issue":"6","key":"3951_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","volume":"3","author":"JW Varni","year":"2003","unstructured":"Varni, J. W., Burwinkle, T. M., Seid, M., & Skarr, D. (2003). The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambulatory Pediatrics, 3(6), 329\u201341.","journal-title":"Ambulatory Pediatrics"},{"issue":"12","key":"3951_CR28","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1007\/s12325-023-02651-6","volume":"40","author":"NVJ Aldhouse","year":"2023","unstructured":"Aldhouse, N. V. J., Kitchen, H., Al-Zubeidi, T., Thursfield, M., Winnette, R., See Tai, S., Zhu, L., Garnier, N., & Baker, C. L. (2023). Development of a conceptual model for the patient experience of focal segmental glomerulosclerosis (FSGS): A qualitative targeted literature review. Advances in Therapy, 40(12), 5155\u20135167.","journal-title":"Advances in Therapy"},{"issue":"4","key":"3951_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.xkme.2021.01.013","volume":"3","author":"NE Carlozzi","year":"2021","unstructured":"Carlozzi, N. E., Massengill, S. F., Trachtman, H., Walsh, L., Singhal, N., LaVigne, J. M., Miner, J. A., Desmond, H. E., Lynam, C., & Gipson, D. S. (2021). Health-related quality of life in focal segmental glomerular sclerosis and minimal change disease: A qualitative study of children and adults to inform patient-reported outcomes. Kidney Med., 3(4), 484-497.e1.","journal-title":"Kidney Med."},{"issue":"2","key":"3951_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1524-4733.2008.00433.x","volume":"12","author":"SN Davison","year":"2009","unstructured":"Davison, S. N., Jhangri, G. S., & Feeny, D. H. (2009). Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease. Value Health, 12(2), 340\u2013345.","journal-title":"Value Health"},{"issue":"12","key":"3951_CR31","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/MLR.0b013e31814848f1","volume":"45","author":"DG Fryback","year":"2007","unstructured":"Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., Herrington, S. A., Hays, R. D., Kaplan, R. M., Ganiats, T. G., Feeny, D., & Kind, P. (2007). US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care, 45(12), 1162\u20131170.","journal-title":"Medical Care"},{"issue":"2","key":"3951_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000455750","volume":"136","author":"HA Nguyen","year":"2017","unstructured":"Nguyen, H. A., Anderson, C. A. M., Miracle, C. M., & Rifkin, D. E. (2017). The association between depression, perceived health status, and quality of life among individuals with chronic kidney disease: An analysis of the National Health and Nutrition Examination Survey 2011\u20132012. Nephron, 136(2), 127\u2013135.","journal-title":"Nephron"},{"issue":"1","key":"3951_CR33","doi-asserted-by":"publisher","first-page":"c24","DOI":"10.1159\/000101481","volume":"106","author":"S Molsted","year":"2007","unstructured":"Molsted, S., Prescott, L., Heaf, J., & Eidemak, I. (2007). Assessment and clinical aspects of health-related quality of life in dialysis patients and patients with chronic kidney disease. Nephron Clinical Practice, 106(1), c24\u2013c33.","journal-title":"Nephron Clinical Practice"},{"issue":"1","key":"3951_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14737167.2021.1854091","volume":"21","author":"H Hussien","year":"2021","unstructured":"Hussien, H., Apetrii, M., & Covic, A. (2021). Health-related quality of life in patients with chronic kidney disease. Expert Review of Pharmacoeconomics & Outcomes Research, 21(1), 43\u201354.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"10075","key":"3951_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic kidney disease. Lancet, 389(10075), 1238\u20131252.","journal-title":"Lancet"},{"key":"3951_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/978-3-031-42045-0_39","volume-title":"Management of chronic kidney disease: A clinician\u2019s guide","author":"RL Morton","year":"2023","unstructured":"Morton, R. L., & Webster, A. C. (2023). Quality of Life in Chronic Kidney Disease. In M. Ar\u0131c\u0131 (Ed.), Management of chronic kidney disease: A clinician\u2019s guide (pp. 579\u2013592). Springer International Publishing."},{"issue":"2","key":"3951_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00000441-200202000-00006","volume":"323","author":"JK Tucker","year":"2002","unstructured":"Tucker, J. K. (2002). Focal segmental glomerulosclerosis in African Americans. American Journal of the Medical Sciences, 323(2), 90\u201393.","journal-title":"American Journal of the Medical Sciences"},{"key":"3951_CR38","unstructured":"Merakoi. Patient advocacy: Why do women advocate more than men? Retrieved from February 20, 2024, https:\/\/merakoi.com\/patient-advocacy-why-do-women-advocate-more-than-men\/"},{"issue":"4","key":"3951_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1681\/ASN.2018100994","volume":"30","author":"JD Peipert","year":"2019","unstructured":"Peipert, J. D., Nair, D., Klicko, K., Schatell, D. R., & Hays, R. D. (2019). Kidney Disease Quality of Life 36-Item Short Form Survey (KDQOL-36) normative values for the United States dialysis population and new single summary score. Journal of the American Society of Nephrology, 30(4), 654\u2013663.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"3951_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer, R. L., Kroenke, K., Williams, J. B., & L\u00f6we, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092\u20131097.","journal-title":"Archives of Internal Medicine"},{"issue":"9","key":"3951_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606\u2013613.","journal-title":"Journal of General Internal Medicine"},{"key":"3951_CR42","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/COPD.S123744","volume":"12","author":"JB Gruenberger","year":"2017","unstructured":"Gruenberger, J. B., Vietri, J., Keininger, D. L., & Mahler, D. A. (2017). Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 12, 937\u2013944.","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"3951_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12888-015-0547-1","volume":"15","author":"S Gupta","year":"2015","unstructured":"Gupta, S., Isherwood, G., Jones, K., & Van Impe, K. (2015). Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. BMC Psychiatry, 15, 162.","journal-title":"BMC Psychiatry"},{"key":"3951_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yebeh.2015.12.018","volume":"55","author":"S Gupta","year":"2016","unstructured":"Gupta, S., Kwan, P., Faught, E., Tsong, W., Forsythe, A., & Ryvlin, P. (2016). Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey. Epilepsy & Behavior, 55, 146\u2013156.","journal-title":"Epilepsy & Behavior"},{"key":"3951_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/DMSO.S83696","volume":"8","author":"S Gupta","year":"2015","unstructured":"Gupta, S., Richard, L., & Forsythe, A. (2015). The humanistic and economic burden associated with increasing body mass index in the EU5. Diabetes Metab Syndr Obes., 8, 327\u2013338.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"2","key":"3951_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/epi4.12050","volume":"2","author":"S Gupta","year":"2017","unstructured":"Gupta, S., Ryvlin, P., Faught, E., Tsong, W., & Kwan, P. (2017). Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil. Epilepsia Open., 2(2), 199\u2013213.","journal-title":"Epilepsia Open."},{"issue":"1","key":"3951_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41533-017-0014-1","volume":"27","author":"ID Pavord","year":"2017","unstructured":"Pavord, I. D., Mathieson, N., Scowcroft, A., Pedersini, R., Isherwood, G., & Price, D. (2017). The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting \u03b2(2)-agonists in the United Kingdom: A cross-sectional analysis. NPJ Prim Care Respir Med., 27(1), 17.","journal-title":"NPJ Prim Care Respir Med."},{"key":"3951_CR48","unstructured":"Strader C, Goren A, DiBonaventura M. 2016 Prevalence of combinations of diabetes complications across NHANES and NHWS. Presented at: 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE, Dublin, Ireland."},{"issue":"5","key":"3951_CR49","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/07853890109002089","volume":"33","author":"RD Hays","year":"2001","unstructured":"Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33(5), 350\u2013357.","journal-title":"Annals of Medicine"},{"issue":"1","key":"3951_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart, E. A. (2010). Matching methods for causal inference: A review and a look forward. Statistical Science, 25(1), 1\u201321.","journal-title":"Statistical Science"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-03951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-025-03951-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-03951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T18:02:15Z","timestamp":1750528935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-025-03951-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3951"],"URL":"https:\/\/doi.org\/10.1007\/s11136-025-03951-w","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"13 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bruce Hendry is an employee of Travere Therapeutics, Inc. and holds stock\/options. Mark Bensink is Managing Director of Benofit Consulting, which received consulting fees from Travere Therapeutics, Inc. for this work. Justyna Szklarzewicz, Ute Floege, Daniel Gallego, Keisha Gibson, Kamyar Kalantar-Zadeh, Kelly Helm, Dale Robinson, Bonnie Schneider, Philip Smith, Kjell Tullus, and Ali Poyan-Mehr received consultancy fees from Travere Therapeutics, Inc. for this work. Bridget L Balkaran and Adam K Jauregui are employees of Oracle Life Sciences, which received consultancy fees from Travere Therapeutics, Inc. for this work. Zheng-Yi Zhou, Nisha C. Hazra, Aolin Wang, Ian Nason, Chunyi Xu, Jingyi Liu are employees of Analysis Group, which received consultancy fees from Travere Therapeutics, Inc. for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}